ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 161 filers reported holding ANIKA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 1.67 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $611,000 | -37.9% | 24,317 | -11.4% | 0.00% | -100.0% |
Q4 2021 | $984,000 | -30.4% | 27,450 | -17.3% | 0.00% | 0.0% |
Q3 2021 | $1,414,000 | -0.6% | 33,212 | +1.0% | 0.00% | 0.0% |
Q2 2021 | $1,423,000 | +68.6% | 32,877 | +58.9% | 0.00% | – |
Q1 2021 | $844,000 | -7.0% | 20,696 | +3.1% | 0.00% | -100.0% |
Q4 2020 | $908,000 | +13.1% | 20,070 | -11.5% | 0.00% | 0.0% |
Q3 2020 | $803,000 | -1.2% | 22,681 | +5.2% | 0.00% | 0.0% |
Q2 2020 | $813,000 | -15.0% | 21,555 | -34.9% | 0.00% | 0.0% |
Q1 2020 | $957,000 | -66.0% | 33,105 | -39.1% | 0.00% | -50.0% |
Q4 2019 | $2,817,000 | +0.5% | 54,330 | +6.3% | 0.00% | 0.0% |
Q3 2019 | $2,804,000 | +36.2% | 51,090 | +0.9% | 0.00% | 0.0% |
Q2 2019 | $2,058,000 | +473.3% | 50,658 | +326.2% | 0.00% | – |
Q1 2019 | $359,000 | -32.0% | 11,887 | -24.4% | 0.00% | -100.0% |
Q4 2018 | $528,000 | -60.9% | 15,723 | -50.9% | 0.00% | 0.0% |
Q3 2018 | $1,350,000 | +268.9% | 31,999 | +179.6% | 0.00% | – |
Q2 2018 | $366,000 | -42.1% | 11,444 | -10.0% | 0.00% | -100.0% |
Q1 2018 | $632,000 | +0.6% | 12,713 | +9.1% | 0.00% | 0.0% |
Q4 2017 | $628,000 | -5.0% | 11,651 | +2.2% | 0.00% | 0.0% |
Q3 2017 | $661,000 | +37.1% | 11,402 | +16.6% | 0.00% | 0.0% |
Q2 2017 | $482,000 | -9.2% | 9,776 | -20.0% | 0.00% | 0.0% |
Q1 2017 | $531,000 | -21.2% | 12,216 | -11.2% | 0.00% | 0.0% |
Q4 2016 | $674,000 | -16.0% | 13,757 | -17.9% | 0.00% | 0.0% |
Q3 2016 | $802,000 | -27.0% | 16,759 | -18.1% | 0.00% | -50.0% |
Q2 2016 | $1,098,000 | +19.6% | 20,471 | -0.3% | 0.00% | +100.0% |
Q1 2016 | $918,000 | +6.2% | 20,537 | -9.3% | 0.00% | 0.0% |
Q4 2015 | $864,000 | +24.0% | 22,646 | +3.4% | 0.00% | 0.0% |
Q3 2015 | $697,000 | -5.4% | 21,891 | -1.9% | 0.00% | 0.0% |
Q2 2015 | $737,000 | -41.7% | 22,326 | -27.3% | 0.00% | -66.7% |
Q1 2015 | $1,264,000 | -22.5% | 30,712 | -23.3% | 0.00% | 0.0% |
Q4 2014 | $1,632,000 | +10.6% | 40,067 | -0.4% | 0.00% | 0.0% |
Q3 2014 | $1,475,000 | -21.1% | 40,241 | -0.2% | 0.00% | -25.0% |
Q2 2014 | $1,869,000 | +46.1% | 40,338 | +29.6% | 0.00% | +33.3% |
Q1 2014 | $1,279,000 | +187.4% | 31,117 | +166.5% | 0.00% | +200.0% |
Q4 2013 | $445,000 | – | 11,674 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Trigran Investments, Inc. | 1,154,183 | $25,761,000 | 3.00% |
CAPITAL MANAGEMENT CORP /VA | 275,130 | $6,141,000 | 1.52% |
Kent Lake Capital LLC | 98,570 | $2,200,000 | 1.21% |
DIKER MANAGEMENT LLC | 21,835 | $487,000 | 0.60% |
Portolan Capital Management | 235,972 | $5,267,000 | 0.53% |
Riverwater Partners LLC | 12,466 | $278,000 | 0.28% |
Ranger Investment Management | 139,661 | $3,117,000 | 0.24% |
Invenomic Capital Management LP | 144,287 | $3,220,000 | 0.23% |
CHATHAM CAPITAL GROUP, INC. | 23,787 | $531,000 | 0.12% |
Teton Advisors, Inc. | 22,000 | $491,000 | 0.10% |